(Q87020959)
Statements
Secukinumab in psoriasis: randomized, controlled phase 3 trial results assessing the potential to improve treatment response in partial responders (STATURE) (English)
D Thaçi
J Humeniuk
Y Frambach
R Bissonnette
J J Goodman
S Shevade
Y Gong
C Papavassilis
STATURE study group